GLP-1 agonist polypeptide compound and salt thereof, synthesis method therefor and use thereof

ChangeBridge: Patent Grants - Peptides (C07K)

Published March 31st, 2026

Detected March 31st, 2026

Summary

USPTO granted patent US12590134B2 to SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD. for a GLP-1 agonist polypeptide compound (SEQ ID NO: 1) used in diabetes and obesity treatment. The patent includes 2 claims covering the compound, salt forms, synthesis method, and therapeutic applications. Filing date was August 17, 2022, under application number 17820251.

View original document View source feed page

What changed

USPTO granted patent US12590134B2 to SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD. covering a GLP-1 agonist polypeptide compound with amino acid sequence H-Xaa1EGTFTSDVSSYLE-Xaa2QAA-Xaa3EFIAWLVRGRG (SEQ ID NO: 1), its salt forms, synthesis methods, and use for treating diabetes (A61P 3/10) and obesity (A61P 3/04). The patent names inventors Chengqing Zhao, Guoqiang Shi, Shunzi Li, and Caidian Wang, and contains 2 claims.\n\nThis is a standard patent grant notification and does not impose compliance obligations. No action is required from other market participants unless they wish to challenge the patent validity or seek licensing arrangements. The patent provides SINOPEP-ALLSINO with exclusive rights to the claimed GLP-1 agonist technology in the United States.

Source document (simplified)

← USPTO Patent Grants

GLP-1 agonist polypeptide compound and salt thereof, synthesis method therefor and use thereof

Grant US12590134B2 Kind: B2 Mar 31, 2026

Assignee

SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.

Inventors

Chengqing Zhao, Guoqiang Shi, Shunzi Li, Caidian Wang

Abstract

The disclosure provides a GLP-1 agonist polypeptide compound having an amino acid sequence: H Xaa1EGTFTSDVSSYLE Xaa2QAA Xaa3EFIAWLVRGRG (SEQ ID NO: 1). The C-terminal amino acid of the polypeptide compound is a carboxyl or the carboxyl is amidated. Xaa1 and Xaa2 are the same or different; R1 is: a straight-chain or branched-chain alkyl containing 2-6 carbon atoms, R2 is: H or CH3, X is: O, S or N—CH3, in the formula, R1 and R2 alkyl is optionally substituted by 1-6 halogen atoms.